69
Participants
Start Date
April 15, 2022
Primary Completion Date
June 5, 2024
Study Completion Date
June 5, 2024
Water
Each subject will receive one control and three treatments in the crossover design. The control contains water only.
Glucose
Each subject will receive one control and three treatments in the crossover design. The glucose contains water and glucose.
Steviol Glycosides
Each subject will receive one control and three treatments in the crossover design. The Steviol Glycoside beverage contains water and steviol glycosides.
Steviol Glycosides plus glucose
Each subject will receive one control and three treatments in the crossover design. The Steviol Glycoside plus glucose beverage contains water, glucose, and steviol glycosides.
Rebaudioside A
A leaf-based, extracted stevia product to compare to the Eversweet in the normal weight group only. The Rebaudioside A contains water and rebaudioside A.
Excellence Medical and Research, Miami Gardens
Advanced Research for Health Improvement, Naples
Great Lakes Clinical Trials, Chicago
Collaborators (1)
Cargill
INDUSTRY
Midwest Center for Metabolic and Cardiovascular Research
OTHER